Previous studies have identified aberrant SAMHD1 expression as a potential cause of colon cancer (7), lung cancer (8), chronic lymphocytic (B-cell) leukemia, and some subtypes of T-cell lymphoma or leukemia (9–11). This evidence concerns the gene SAMHD1 and B-cell chronic lymphocytic leukemia.